Pharmaceutical Market Europe • December 2024 • 45
APPOINTMENTS
Novartis
Johan Kahlström
Novartis has appointed Johan Kahlström as country president and managing director of Novartis UK and Ireland. Kahlström has extensive experience within the pharmaceutical industry. He has held multiple senior European and global commercial roles during more than two decades at Novartis, including in the Netherlands, Switzerland and China, and most recently led Novartis Nordics as its country president and managing director. Kahlström originally joined the company as associate, clinical safety and epidemiology, and has since held roles of increasing responsibility and across multiple therapeutic areas. His previous positions include global marketing head of heart failure, and head of strategy and new product launch in China. He also currently serves as a board member of the Swedish Association of the Pharmaceutical Industry.
LEO Pharma
Kristian Sibilitz
LEO Pharma has appointed Kristian Sibilitz as executive vice president, technical development and supply. Sibilitz, who has also been appointed as a member of the company’s global leadership team, brings extensive experience to the role, having spent over 19 years at Lundbeck in various leadership roles within product development and supply.
ALX Oncology
Alan Sandler
ALX Oncology has appointed Alan Sandler as chief medical officer. Sandler brings extensive industry experience to the role and previously held the position of executive vice president, chief medical officer at Mirati Therapeutics. He also served as president, global head of development in oncology at Zai Lab and held roles of increasing responsibility at Genentech.
Actimed Therapeutics
David Ebsworth
Actimed Therapeutics has appointed David Ebsworth as executive chairman. Ebsworth has over 40 years of experience in the healthcare industry and has been serving as non-executive chairman of Actimed for the past six years. He was previously chief executive director of Galenica and Vifor Pharma, and global head of the pharmaceutical division at Bayer.
Seaport Therapeutics
Sandra Peterson
Seaport Therapeutics has appointed Sandra Peterson to its board of directors. Peterson previously served as chairman and chief executive officer of Bayer CropScience and as chief executive officer of Bayer Medical Care. She is currently an operating partner at Clayton, Dubilier & Rice and was group worldwide chair for Johnson & Johnson.
Actimed Therapeutics
Stefan Anker
Actimed Therapeutics has appointed Stefan Anker as non-executive director. Anker, who is chair of the company's scientific advisory board, joins the board of directors with 30 years of academic research experience in cachexia and clinical trials development. He co-founded Actimed seven years ago, having previously founded Myotec.
NanoVation Therapeutics
David Main
NanoVation Therapeutics has appointed David Main to its board of directors. Main has 30 years of biotechnology leadership experience and is currently president and chief executive officer of Notch Therapeutics. Previously, he was co-founder, chairman and chief executive officer of Aquinox Pharmaceuticals, and president and chief executive officer of INEX Pharmaceuticals.
Mestag Therapeutics
Jan Endell
Mestag Therapeutics has appointed Jan Endell as senior vice president, head of development. Endell holds over 15 years of experience in drug development and most recently served as chief scientific officer at Veraxa Biotech. He was also previously vice president of preclinical development at Affimed and held multiple positions at Morphosys.
MinervaX
Veronica Gambillara Fonck
MinervaX has appointed Veronica Gambillara Fonck as chair of its board of directors. Fonck has over 18 years of experience across the pharma and biotech industry in various operational roles in vaccine development. She was previously the co-founder and chief executive officer of LimmaTech Biologic and GlycoEra. She is also a board member at Memo Therapeutics.
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services